Compare Noble Corporation plc (NE) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Noble Corporation plc vs Regeneron Pharmaceuticals Inc — how do they compare? Noble Corporation plc trades at $42.53 (market cap $6.48B), while Regeneron Pharmaceuticals Inc trades at $680.5 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 10.9× Noble Corporation plc's market cap, and Noble Corporation plc pays the higher dividend (4.93%). Which is the better fit depends on your goals.
| NE | REGN | |
|---|---|---|
Market Cap | $6.48B | $70.47B |
Sector | Technology | Health |
52-Week High | $54.37 | $812.27 |
52-Week Low | $25.70 | $545.46 |
Enterprise Value | $7.73B | $64.42B |
Dividend Yield | 4.93% | 0.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Noble Corporation (NE) trades at $40.60, down 2.17% today, with mixed technical signals showing a bullish moving average trend but bearish oscillators. The company maintains solid fundamentals with a $3.29B revenue in 2025 and a net income margin of 7.17%, supported by recent contract wins like the $136.2M Brunei drilling deal. Cash flow remains positive, and a $0.50 dividend was recently declared, payable in June 2026.
The outlook is cautiously optimistic with a consensus price target of $49.75 offering 22.5% upside, though recent earnings misses and competitive pressures in offshore drilling pose risks. Analyst sentiment is divided with 31% buy ratings, reflecting confidence in Noble's high-specification rig fleet and contract backlog, balanced by execution challenges and oil price volatility.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Noble Corporation plc
Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
